All Outputs (3)

Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus (2017)
Journal Article
Pereira, M., Gohin, S., Roux, J.-P., Fisher, A., Cleasby, M. E., Mabilleau, G., & Chenu, C. (2017). Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus. Frontiers in Endocrinology, 8(327), https://doi.org/10.3389/fendo.2017.00327

Type 2 diabetes mellitus (T2DM) is associated with skeletal complications, including an
increased risk of fractures. Reduced blood supply and bone strength may contribute to
this skeletal fragility. We hypothesized that long-term administration of... Read More about Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus.

Prolonging disuse in aged mice amplifies cortical but not trabecular bones’ response to mechanical loading (2017)
Journal Article
De Souza, R., Javaheri, B., Collinson, R. S., Chenu, C., Shefelbine, S., Lee, P. D., & Pitsillides, A. A. (2017). Prolonging disuse in aged mice amplifies cortical but not trabecular bones’ response to mechanical loading

Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus (2017)
Journal Article
Pereira, M., Gohin, S., Lund, N., Hvid, A., Smitham, P. J., Oddy, M. J., Reichert, I., Farley, D., Roux, J. P., Cleasby, M. E., & Chenu, C. (2017). Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus. Osteoporosis International, 28(1), 309-320. https://doi.org/10.1007/s00198-016-3718-0